"Changes in Acute Migraine-specific Medications After Initiating Erenumab: Results from a Real-world Retrospective Cohort Study in the United States (1685)." Neurology
94.15 Supplement
(2020):
1685.
Web. 05 Feb. 2023.
Advertisement
The most widely read and highly cited peer-reviewed neurology journal
